Sector Alpha Week of 2026-09-17
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-17

The Boeing Company

BA
Industrials · Aerospace & Defense

The Boeing Company's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding.

The price is building a base (5 weeks in). Underneath, the last four quarters read improving. What settles it: the next one or two quarters of delivery.

Price
$202
−6.3% 1Y
P/E
78.2×
vs its own history
Revenue (Jun 26)
$24.6 B
+8.0% YoY
Profit (Jun 26)
$−0.4 B
Operating margin
0.7%
+1.5 pp YoY
ROE
174%
FY25
ROIC
−12.7%
vs WACC 9.5% → −22.2 pp
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

The Boeing Company trades at $202, building a base and 5 weeks into that stage. That is −8.7% against its own 200-day average. It sits at 31% of a 52-week range of $180 to $252. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (27 weeks and counting).

Today the stock is building a base — week 5 of stage 1. At $202 it trades −8.7% versus its 200-day average and sits at 31% of its 52-week range ($180–$252).

Sep 26: $202 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−8.7% versus the 200-day line, week 5 of stage 1
Price50-day avg200-day avg
S2S1S4S3S3S2S2$274$237$200$163$126$$202$221Sep 23Jun 24Mar 25Dec 25Sep 26
S2S1S4S3S3S2S2$274$237$200$163$126$$202$221Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (533 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved +55% while the S&P 500 moved +255% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (27 weeks and counting; last ahead the week of 2026-03-13) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

The Boeing Company trades at 78.2× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 78.2× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.

PEG 8.17 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 20 quarters; values above 6 pinned at the top.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
6.4×5.0×3.5×2.0×0.6××6.00×Sep 21Sep 22Dec 23Mar 25Jun 26
6.4×5.0×3.5×2.0×0.6××6.00×Sep 21Dec 23Jun 26
P/E
78.2×
too little history to rank
PEG
1.57
as reported

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

The Boeing Company reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.

Growth, year by year: revenue +34.5% in FY25 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoY
38%24%10%−4.2%−18%%34.5%FY21FY23FY25
38%24%10%−4.2%−18%%34.5%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating
Revenue
38%24%10%−4.2%−18%%24.8%Sep 23Dec 24Jun 26
38%24%10%−4.2%−18%%24.8%Sep 23Dec 24Jun 26
ROE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROE
326%242%158%74%−10%%41%FY22FY23FY25
326%242%158%74%−10%%41%FY22FY23FY25
Revenue growth
Rising
latest +24.8% · span −14.5% to +34.5%
ROE
Steady high
latest 41.0% · span 13.0%–302.6%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+34.5%+10.3%
Stock price−6.3%−1.0%−1.1%+4.8%
Revenue YoY (Jun 26)
+8.0%
latest quarter vs a year ago
Revenue 10y
9.5%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

43.8/100 — rank 18 of 30 in Aerospace & Defense · 64% evidence confidence

The Boeing Company scores 43.8 out of 100 against the 30 companies it is compared with in Aerospace & Defense, ranking 18. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 19.8 + 4.1 + 9 + 10.9 = 43.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

The Boeing Company reported $24.6 B of revenue in the Jun 26 quarter, +8.0% year on year. That is the 6th straight quarter of year-on-year growth. Over 4 years it has compounded at 9.5% a year. The last full year, FY25, came in at $89.5 B. The last four reported quarters add to $94.0 B.

FY25 revenue came in at $89.5 B (+34.5% on the year), capping 4 years at 9.5% compound. The latest quarter (Jun 26) printed $24.6 B, +8.0% year on year — the 6th consecutive quarter of year-over-year growth.

FY25 revenue $89.5 B (+34.5% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
9.5% a year over 4 years
RevenueYoY growth
9738%7224%4810%24−4.2%0.0−18%$ B%$90B34.5%FY21FY23FY25
9738%7224%4810%24−4.2%0.0−18%$ B%$90B34.5%FY21FY23FY25
Jun 26: $24.6 B (+8.0% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
6th straight quarter of growth
Revenue (quarterly)YoY growth
2764%2039%1313%6.6−12%0.0−38%$ B%$25B8%Sep 23Dec 24Jun 26
2764%2039%1313%6.6−12%0.0−38%$ B%$25B8%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +27.4% growth against the decade's 9.5% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +24.8% over the last 4 quarters against +13.0%/yr over the last 8 — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

The Boeing Company's operating margin is 0.7% in the Jun 26 quarter, +1.5 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged −16.1% to 4.8%. The current quarter sits inside that band.

The latest quarter's operating margin is 0.7%, +1.5 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −16.1%–4.8%, and FY25's 4.8% is the top of that band — a record year.

Why the margin moved: operating margin went +1.5 pp year on year while gross margin went −0.9 pp — the gain came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

FY25: 4.8% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
the widest a −16.1–4.8% band over 5 years
operating marginYoY change (pp)
6.5%24%0.4%13%−5.7%2.9%−12%−7.5%−18%−18%%%4.8%20.9%FY21FY23FY25
6.5%24%0.4%13%−5.7%2.9%−12%−7.5%−18%−18%%%4.8%20.9%FY21FY23FY25
Jun 26: 0.7% operating margin (+1.5 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
42%69%22%43%2.2%17%−18%−9.1%−38%−35%%%0.7%1.5%Sep 23Dec 24Jun 26
42%69%22%43%2.2%17%−18%−9.1%−38%−35%%%0.7%1.5%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

The Boeing Company posted a net loss of $0.4 B in the Jun 26 quarter. Full-year FY25 profit was $2.2 B. That loss is 1.8% of the quarter's revenue. The same quarter a year earlier lost $0.6 B. 11 of the last 12 reported quarters were loss-making.

Jun 26 profit was $−0.4 B, null year on year. On the full year, FY25 printed $2.2 B (null).

FY25 profit $2.2 B (null YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profit
3.4−0.7−4.8−8.9−13$ B$2BFY21FY23FY25
3.4−0.7−4.8−8.9−13$ B$2BFY21FY23FY25
Jun 26: $−0.4 B (null YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)
9.45.21.0−3.1−7.3$ B$−0BSep 23Dec 24Jun 26
9.45.21.0−3.1−7.3$ B$−0BSep 23Dec 24Jun 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

The Boeing Company's cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $1.1 B of operating cash against $2.2 B of profit. After $2.9 B of capital spending, $−1.9 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY25: operating cash of $1.1 B against reported profit of $2.2 B, leaving free cash of $−1.9 B after $2.9 B of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $1.1 B vs profit $2.2 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
Operating cashNet profitFree cash
7.61.7−4.2−10−16$ B$1B$2B$−2BFY21FY23FY25
7.61.7−4.2−10−16$ B$1B$2B$−2BFY21FY23FY25
Jun 26: operating cash $1.4 B Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
4.0107%1.882%−0.358%−2.434%−4.59.3%$ B%$1B16%Sep 23Dec 24Jun 26
4.0107%1.882%−0.358%−2.434%−4.59.3%$ B%$1B16%Sep 23Dec 24Jun 26

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

The Boeing Company does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $7.0 B over the last 3 years. Averaged over those years that is 2.6% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $7.0 B over the last 3 fiscal years.

FY25: capex $2.9 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
3.22.41.60.80.0$ B$3BFY21FY23FY25
3.22.41.60.80.0$ B$3BFY21FY23FY25
Jun 26: capex $0.7 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
1.43.51.01.40.7−0.70.3−2.80.0−4.9$ B$ B$1B$1BSep 23Dec 24Jun 26
1.43.51.01.40.7−0.70.3−2.80.0−4.9$ B$ B$1B$1BSep 23Dec 24Jun 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

The Boeing Company earns a ROE of 41% in FY25. That is up from a trough of 13% in FY23. Return on invested capital clears the cost of that capital by −22.2 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 2.5% net margin on 0.53× asset turns.

FY25 ROE is 41%, recovered from a FY23 trough of 13% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY25): 2.5% net margin × 0.53× asset turns × 30.81× balance-sheet leverage ≈ 40.8% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: −12.7% − 9.5% = a −22.2 pp spread. The 9.5% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY25: ROE 41% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 9.5% cost of capital used on this page.
the climb back from FY23's 13%
ROEROIC (annual)WACC
328%235%141%47%−46%%41%8.1%FY21FY23FY25
328%235%141%47%−46%%41%8.1%FY21FY23FY25
Jun 26: ROIC 12.8% (TTM) vs WACC 9.5% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
1,153%835%518%200%−118%%12.8%−30.4%Sep 23Dec 24Jun 26
1,153%835%518%200%−118%%12.8%−30.4%Sep 23Dec 24Jun 26
11 · Dividend

Dividend

The Boeing Company pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

The Boeing Company does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

The Boeing Company carries total debt of $45.9 B against shareholder equity of $6.1 B as of Jun 26, a debt-to-equity of 7.50. On the annual view that ratio went from −3.91 in FY21 to 9.91 in FY25. Read the returns elsewhere on this page with that leverage in mind.

Jun 26: total debt of $45.9 B against shareholder equity of $6.1 B — a debt-to-equity of 7.50. On the annual view, debt-to-equity went from −3.91 (FY21) to 9.91 (FY25). Read the returns on this page with that leverage in mind.

FY25: debt $54.1 B at 9.91× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
6311.8×474.9×31−1.9×16−8.8×0.0−15.7×$ B×$54B9.91×FY21FY23FY25
6311.8×474.9×31−1.9×16−8.8×0.0−15.7×$ B×$54B9.91×FY21FY23FY25
Jun 26: debt $45.9 B, debt-to-equity 7.50 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
6312.0×474.4×31−3.1×16−10.7×0.0−18.2×$ B×$46B7.50×Sep 23Dec 24Jun 26
6312.0×474.4×31−3.1×16−10.7×0.0−18.2×$ B×$46B7.50×Sep 23Dec 24Jun 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

0.0% of The Boeing Company's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 0.0 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 0.0% of the float is sold short, and at typical trading volumes it would take about 0.0 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
0.0%
of the tradable float
Days to cover
0.0
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

The Boeing Company: the Z-score reads 1.35. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

🚨 Why it matters: a Z-score of 1.35 is inside the distress zone — the balance sheet is a real risk, not a detail.

The safety line in one sentence: the Z-score reads 1.35.

15 · Related companies · Aerospace & Defense
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Lockheed Martin CorporationLMT 72.1/100Favorable setup81% evidence TURNING 25.6/35 Revenue 7.2% · PAT 49.5% · OPM change 8.3 pp 83% evidence 14.5/25 ROCE 6.8% · OPM 12.4% 76% evidence 16.1/20 P/E 18.7× · PEG 0.35 65% evidence 15.9/20 RS sector 5.2% · RS bench -8% · 1Y 13.6%4 of 12 weeks ahead 100% evidence
Exact sum: 25.6 + 14.5 + 16.1 + 15.9 = 72.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2RTX CorporationRTX 65.8/100Favorable setup81% evidence BREAKING OUT 21.5/35 Revenue 11.8% · PAT 26.1% · OPM change 1.2 pp 83% evidence 15.2/25 ROCE 10.4% · OPM 12.7% 76% evidence 12.1/20 P/E 33× · PEG 1.33 65% evidence 17.0/20 RS sector 10.7% · RS bench -2.8% · 1Y 24.4%8 of 12 weeks ahead 100% evidence
Exact sum: 21.5 + 15.2 + 12.1 + 17 = 65.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3HEICO CorporationHEI 60.0/100Mixed-positive evidence81% evidence ASLEEP 24.3/35 Revenue 18.8% · PAT 30.2% · OPM change 2.9 pp 83% evidence 14.7/25 ROCE 4.3% · OPM 25.5% 76% evidence 10.4/20 P/E 48.2× · PEG 1.56 65% evidence 10.6/20 RS sector -0.7% · RS bench -12.7% · 1Y -6.1%8 of 12 weeks ahead 100% evidence
Exact sum: 24.3 + 14.7 + 10.4 + 10.6 = 60 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Elbit Systems Ltd.ESLT 59.8/100Mixed-positive evidence81% evidence ASLEEP 22.4/35 Revenue 13.7% · PAT 60.2% · OPM change 1.6 pp 83% evidence 11.7/25 ROCE 3.1% · OPM 9.6% 76% evidence 11.7/20 P/E 57.2× · PEG 1.13 65% evidence 14.0/20 RS sector 12.2% · RS bench -1.9% · 1Y 51.3%1 of 12 weeks ahead 100% evidence
Exact sum: 22.4 + 11.7 + 11.7 + 14 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Howmet Aerospace Inc.HWM 59.7/100Mixed-positive evidence81% evidence ASLEEP 24.6/35 Revenue 18.1% · PAT 33.9% · OPM change 2.5 pp 83% evidence 16.3/25 ROCE 7% · OPM 27.9% 76% evidence 9.0/20 P/E 57.9× · PEG 1.62 65% evidence 9.8/20 RS sector 2.6% · RS bench -9.8% · 1Y 19.7%3 of 12 weeks ahead 100% evidence
Exact sum: 24.6 + 16.3 + 9 + 9.8 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Embraer S.A.EMBJ 58.3/100Mixed-positive evidence66% evidence BREAKING OUT 16.5/35 Revenue 20% · PAT -22.2% · OPM change 1 pp 53% evidence 7.6/25 ROCE 1.1% · OPM 5.6% 57% evidence 14.2/20 P/E 54.9× · PEG 0.51 65% evidence 20.0/20 RS sector 21% · RS bench 6.4% · 1Y 27.7%8 of 12 weeks ahead 100% evidence
Exact sum: 16.5 + 7.6 + 14.2 + 20 = 58.3 · Decision use: Price leads the evidence: RS versus the benchmark is 6.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
7General Dynamics CorporationGD 56.7/100Thin evidence · provisional58% evidence FADING 17.0/35 Revenue — · PAT — · OPM change 0.1 pp 45% evidence 12.5/25 ROCE 3.7% · OPM 10.4% 76% evidence 11.0/20 P/E 22.8× · PEG — 15% evidence 16.2/20 RS sector 8.7% · RS bench -4.4% · 1Y 11.1%6 of 12 weeks ahead 100% evidence
Exact sum: 17 + 12.5 + 11 + 16.2 = 56.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
8Hexcel CorporationHXL 56.0/100Thin evidence · provisional56% evidence FADING 20.8/35 Revenue — · PAT — · OPM change 1.8 pp 39% evidence 10.8/25 ROCE 2.9% · OPM 11.5% 76% evidence 10.0/20 P/E 50.3× · PEG — 15% evidence 14.4/20 RS sector 14.1% · RS bench 0.4% · 1Y 47.2%7 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 10.8 + 10 + 14.4 = 56 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9GE AerospaceGE 54.5/100Mixed-positive evidence81% evidence ASLEEP 19.4/35 Revenue 21.7% · PAT 16.2% · OPM change -0.3 pp 83% evidence 16.4/25 ROCE 11.7% · OPM 20.6% 76% evidence 7.3/20 P/E 43.5× · PEG 2.38 65% evidence 11.4/20 RS sector 4.8% · RS bench -7.8% · 1Y 3.9%8 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 16.4 + 7.3 + 11.4 = 54.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Curtiss-Wright CorporationCW 52.7/100Mixed-positive evidence81% evidence ASLEEP 21.8/35 Revenue 10.5% · PAT 20% · OPM change 1.5 pp 83% evidence 19.5/25 ROCE 17.4% · OPM 19.4% 76% evidence 7.4/20 P/E 51.7× · PEG 2.28 65% evidence 4.0/20 RS sector -6.4% · RS bench -17.9% · 1Y 10.7%0 of 12 weeks ahead 100% evidence
Exact sum: 21.8 + 19.5 + 7.4 + 4 = 52.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Woodward, Inc.WWD 52.6/100Thin evidence · provisional56% evidence ASLEEP 20.4/35 Revenue — · PAT — · OPM change 1.2 pp 39% evidence 14.3/25 ROCE 4.9% · OPM 14.7% 76% evidence 9.9/20 P/E 50.5× · PEG — 15% evidence 8.0/20 RS sector -0.2% · RS bench -12.5% · 1Y 33.7%1 of 12 weeks ahead 100% evidence
Exact sum: 20.4 + 14.3 + 9.9 + 8 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12Loar Holdings Inc.LOAR 50.3/100Thin evidence · provisional56% evidence ASLEEP 18.7/35 Revenue 26.3% · PAT 91.7% · OPM change -1.3 pp 53% evidence 10.3/25 ROCE 1.8% · OPM 21.5% 57% evidence 9.1/20 P/E 80.7× · PEG — 15% evidence 12.2/20 RS sector -0.4% · RS bench -12.4% · 1Y -19.2%7 of 12 weeks ahead 100% evidence
Exact sum: 18.7 + 10.3 + 9.1 + 12.2 = 50.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
13Leonardo DRS, Inc.DRS 49.0/100Thin evidence · provisional56% evidence ASLEEP 20.3/35 Revenue — · PAT — · OPM change 1.7 pp 39% evidence 11.8/25 ROCE 3.3% · OPM 9.1% 76% evidence 10.7/20 P/E 35.9× · PEG — 15% evidence 6.2/20 RS sector -4% · RS bench -15.9% · 1Y -10.5%2 of 12 weeks ahead 100% evidence
Exact sum: 20.3 + 11.8 + 10.7 + 6.2 = 49 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
14Textron Inc.TXT 46.2/100Thin evidence · provisional56% evidence BASING 15.9/35 Revenue — · PAT — · OPM change -0.8 pp 39% evidence 9.3/25 ROCE 2% · OPM 6.3% 76% evidence 11.3/20 P/E 17.4× · PEG — 15% evidence 9.7/20 RS sector -2.9% · RS bench -14.9% · 1Y -3.5%1 of 12 weeks ahead 100% evidence
Exact sum: 15.9 + 9.3 + 11.3 + 9.7 = 46.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
15Northrop Grumman CorporationNOC 44.9/100Mixed-negative evidence81% evidence TURNING 9.9/35 Revenue 5.9% · PAT 14% · OPM change -3.7 pp 83% evidence 10.7/25 ROCE 3% · OPM 10.1% 76% evidence 14.5/20 P/E 16.2× · PEG 1.01 65% evidence 9.8/20 RS sector -5.5% · RS bench -17.5% · 1Y -7.4%0 of 12 weeks ahead 100% evidence
Exact sum: 9.9 + 10.7 + 14.5 + 9.8 = 44.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
16Axon Enterprise, Inc.AXON 44.8/100Mixed-negative evidence71% evidence BREAKING OUT 20.0/35 Revenue 34.6% · PAT -39% · OPM change 5.4 pp 83% evidence 6.4/25 ROCE 0.9% · OPM 5.2% 76% evidence 8.6/20 P/E 232.6× · PEG — 15% evidence 9.8/20 RS sector -6.2% · RS bench -17.4% · 1Y -39.5%11 of 12 weeks ahead 100% evidence
Exact sum: 20 + 6.4 + 8.6 + 9.8 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17CAE Inc.CAE 44.4/100Mixed-negative evidence66% evidence ASLEEP 10.7/35 Revenue 4.4% · PAT -22.4% · OPM change -7.6 pp 53% evidence 10.7/25 ROCE 2% · OPM 12.9% 57% evidence 14.7/20 P/E 37.3× · PEG 0.68 65% evidence 8.3/20 RS sector -6.5% · RS bench -18.1% · 1Y -14%0 of 12 weeks ahead 100% evidence
Exact sum: 10.7 + 10.7 + 14.7 + 8.3 = 44.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
18The Boeing Companythis pageBA 43.8/100Mixed-negative evidence64% evidence ASLEEP 19.8/35 Revenue 24.8% · PAT — · OPM change 1.4 pp 62% evidence 4.1/25 ROCE 0.3% · OPM 0.6% 76% evidence 9.0/20 P/E 93.7× · PEG — 15% evidence 10.9/20 RS sector -1.2% · RS bench -13.4% · 1Y -6.3%0 of 12 weeks ahead 100% evidence
Exact sum: 19.8 + 4.1 + 9 + 10.9 = 43.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Huntington Ingalls Industries, Inc.HII 43.6/100Thin evidence · provisional56% evidence BASING 16.6/35 Revenue — · PAT — · OPM change -0.9 pp 39% evidence 9.4/25 ROCE 2.2% · OPM 5% 76% evidence 11.4/20 P/E 16.7× · PEG — 15% evidence 6.2/20 RS sector -11.8% · RS bench -23.2% · 1Y 1.1%0 of 12 weeks ahead 100% evidence
Exact sum: 16.6 + 9.4 + 11.4 + 6.2 = 43.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
20StandardAero, Inc.SARO 42.9/100Thin evidence · provisional56% evidence ASLEEP 18.4/35 Revenue 15% · PAT 100% · OPM change -0.2 pp 53% evidence 9.2/25 ROCE 2.8% · OPM 8.8% 57% evidence 10.9/20 P/E 29.4× · PEG — 15% evidence 4.4/20 RS sector -10.4% · RS bench -21.6% · 1Y -16.1%4 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 9.2 + 10.9 + 4.4 = 42.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
21TransDigm Group IncorporatedTDG 41.7/100Mixed-negative evidence81% evidence ASLEEP 15.3/35 Revenue 16.6% · PAT 10.3% · OPM change -1.6 pp 83% evidence 15.9/25 ROCE 5.5% · OPM 44.8% 76% evidence 5.3/20 P/E 40.2× · PEG 4.28 65% evidence 5.2/20 RS sector -9.4% · RS bench -20.5% · 1Y -15.8%0 of 12 weeks ahead 100% evidence
Exact sum: 15.3 + 15.9 + 5.3 + 5.2 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Rocket Lab CorporationRKLB 40.5/100Mixed-negative evidence61% evidence ASLEEP 25.1/35 Revenue 52.6% · PAT — · OPM change 16.7 pp 62% evidence 3.1/25 ROCE -2.4% · OPM -24.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 2.3/20 RS sector -9.3% · RS bench -20.5% · 1Y 33.3%2 of 12 weeks ahead 100% evidence
Exact sum: 25.1 + 3.1 + 10 + 2.3 = 40.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -9.3% and the one-year return is 33.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
23L3Harris Technologies, Inc.LHX 39.8/100Thin evidence · provisional58% evidence BASING 17.3/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence 10.2/25 ROCE 1.9% · OPM 11.1% 76% evidence 8.8/20 P/E 96× · PEG — 15% evidence 3.5/20 RS sector -13% · RS bench -24% · 1Y -11.7%0 of 12 weeks ahead 100% evidence
Exact sum: 17.3 + 10.2 + 8.8 + 3.5 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
24FTAI Aviation Ltd.FTAI 38.4/100Thin evidence · provisional56% evidence ASLEEP 12.8/35 Revenue — · PAT — · OPM change -9.6 pp 39% evidence 13.4/25 ROCE 5% · OPM 20.5% 76% evidence 9.2/20 P/E 58.8× · PEG — 15% evidence 3.0/20 RS sector -8% · RS bench -19.9% · 1Y 6.1%0 of 12 weeks ahead 100% evidence
Exact sum: 12.8 + 13.4 + 9.2 + 3 = 38.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
25AeroVironment, Inc.AVAV 37.7/100Mixed-negative evidence71% evidence BASING 17.6/35 Revenue 100% · PAT -702.3% · OPM change 3.9 pp 83% evidence 6.1/25 ROCE 1.8% · OPM 8.9% 76% evidence 8.7/20 P/E 97.8× · PEG — 15% evidence 5.3/20 RS sector -28.4% · RS bench -37.4% · 1Y -43.8%2 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 6.1 + 8.7 + 5.3 = 37.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Kratos Defense & Security Solutions, Inc.KTOS 37.1/100Thin evidence · provisional56% evidence ASLEEP 18.2/35 Revenue 21.9% · PAT 50% · OPM change -0.9 pp 53% evidence 6.4/25 ROCE 0.2% · OPM 1.3% 57% evidence 8.5/20 P/E 423.2× · PEG — 15% evidence 4.0/20 RS sector -30.2% · RS bench -39.4% · 1Y -41.1%1 of 12 weeks ahead 100% evidence
Exact sum: 18.2 + 6.4 + 8.5 + 4 = 37.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
27BWX Technologies, Inc.BWXT 34.2/100Adverse evidence66% evidence ASLEEP 16.4/35 Revenue 21.4% · PAT 19% · OPM change -1.8 pp 53% evidence 11.2/25 ROCE 2.7% · OPM 9.9% 57% evidence 5.3/20 P/E 54.7× · PEG 2.86 65% evidence 1.3/20 RS sector -18.7% · RS bench -28.8% · 1Y -16.5%0 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 11.2 + 5.3 + 1.3 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Moog Inc.MOG-B 53.2/100Thin evidence · provisional33% evidence FADING 19.5/35 Revenue — · PAT — · OPM change 1 pp 32% evidence 13.1/25 ROCE 4.4% · OPM 10.8% 76% evidence 10.6/20 P/E 36.1× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y 86.1%9 of 11 weeks ahead 0% evidence
Exact sum: 19.5 + 13.1 + 10.6 + 10 = 53.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Honeywell Aerospace Inc.HONA 42.7/100Thin evidence · provisional48% evidence ASLEEP 7.2/35 Revenue 10.1% · PAT -32.7% · OPM change -10.5 pp 83% evidence 15.5/25 ROCE 8.9% · OPM 12.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 1 week ahead 0% evidence
Exact sum: 7.2 + 15.5 + 10 + 10 = 42.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30Space Exploration Technologies Corp.SPCX 39.8/100Thin evidence · provisional33% evidence ASLEEP 16.4/35 Revenue — · PAT — · OPM change 17.2 pp 39% evidence 3.4/25 ROCE -1.6% · OPM -1.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 1 week ahead 0% evidence
Exact sum: 16.4 + 3.4 + 10 + 10 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is The Boeing Company's stock price today?

The Boeing Company trades at $202, −6.3% over the past year. The company is valued at $160 B. The stock sits at 31% of its 52-week range of $180–$252, −8.7% versus its 200-day average. On the tape, the price is building a base, 5 weeks in. — as of 17 September 2026.

What were The Boeing Company's latest quarterly results?

The Boeing Company reported revenue of $24.6 B and a net loss of $0.4 B for the Jun 26 quarter. Earnings per share were $−0.67. The operating margin was 0.7%, 1.5 pp higher than a year earlier. — as of 17 September 2026.

What is The Boeing Company's revenue?

The Boeing Company reported revenue of $24.6 B in the Jun 26 quarter, +8.0% year on year. For the full FY25 fiscal year, revenue was $89.5 B (+34.5%). Over the last 4 years revenue compounded at 9.5% a year. — as of 17 September 2026.

What is The Boeing Company's profit?

The Boeing Company earned $−0.4 B of net profit in the Jun 26 quarter. Full-year FY25 profit was $2.2 B. The operating margin ran 0.7% in the latest quarter. — as of 17 September 2026.

What is The Boeing Company's market cap?

The Boeing Company's market capitalisation is $160 B at a stock price of $202. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.

Does The Boeing Company pay a dividend?

No — The Boeing Company has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 17 September 2026.

How is The Boeing Company performing?

The Boeing Company is building a base, 5 weeks in. Against the S&P 500 it has been behind on a trailing-13-week view for 27 weeks. This describes what the data did, not a rating. — as of 17 September 2026.

Is The Boeing Company in an uptrend?

No — the price is building a base (week 5 of stage 1), trading −8.7% versus its 200-day average and at 31% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.

Is The Boeing Company beating the market?

Not lately — on a trailing-13-week view The Boeing Company is currently behind the S&P 500 (27 weeks and counting; last ahead the week of 2026-03-13), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved +55% against the S&P 500's +255% — behind the index over the full window. — as of 17 September 2026.

Will The Boeing Company's stock price go up?

This page publishes no price forecast for The Boeing Company. What it measures instead: the stock price is $202, the price is building a base 5 weeks in. Direction is not something this site claims to know. — as of 17 September 2026.

Is the market betting against The Boeing Company?

No — short interest is 0.0% of The Boeing Company's tradable float, about 0.0 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.

Does The Boeing Company have too much debt?

It carries real leverage — The Boeing Company's debt-to-equity is 7.91. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 17 September 2026.

What is The Boeing Company's capex?

The Boeing Company spent $7.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $2.9 B. — as of 17 September 2026.

What is The Boeing Company's cash flow?

The Boeing Company generated $1.1 B of operating cash flow in FY25 and $−1.9 B of free cash flow after $2.9 B of capital spending. Reported profit that year was $2.2 B, so operating cash ran behind profit. — as of 17 September 2026.

How financially safe is The Boeing Company?

On the balance sheet, the Z-score reads 1.35 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 17 September 2026.

Where is The Boeing Company in its business cycle?

The Boeing Company's FY25 operating margin was 4.8%, against a 5-year band of −16.1%–4.8%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 0.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.

What could break the The Boeing Company story?

Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.

Is The Boeing Company a stock worth studying right now?

This is not investment advice. The machine read: The Boeing Company's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-17. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI